lilly retatrutide trial ESC 2024: improves lipid and cardiovascular risk profile in Phase II A new clinical trial from

PMID: 18577568

Protein Protein has long been associated with feeling fuller after meals, and GLP-1 helps explain why

What medical comorbidities are associated with NAFLD

Three personalized paths to better GLP-1 care Through Castlights GLP-1 & Weight Management Program, members receive a personalized plan informed by experts and built around their unique needs

Review bloodwork, assess side effects, discuss dose optimization, and evaluate progress against expectations

New Study Recommends Stopping GLP-1 Agonists 14 Days Before Total Joint Arthroplasty to Reduce Anesthesia Risks SAN DIEGO (March 10, 2025)Glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as semaglutide (e.g., Ozempic), have helped improve the management of type 2 diabetes and obesity